Clinical Trial

CAS for Stenosis With High-risk Features for CEA

Study acronym: HeartCare CAS
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this prospective, multicenter, single-group target-value study is to evaluate the safety and efficacy of the carotid artery stent system in patients with high-risk features for carotid endarterectomy. This trial is utilizing the carotid artery stent system provided by Shanghai HeartCare Medical Technology Co., Ltd. and will be conducted at approximately 10 interventional neurology centers in China.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-04-15
notable Trial sites expanded: 0 -> 16 locations 2026-04-15
Trial Details
NCT Number NCT07370246
Lead Sponsor Beijing Tiantan Hospital
Collaborators: Shanghai HeartCare Medical Technology Co., Ltd.
Conditions Carotid Artery Stenosis, Carotid Artery Stenting
Enrollment 212 participants
Start Date 2026-03-06
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-14